Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery

Anticancer Res. 2017 Aug;37(8):4215-4222. doi: 10.21873/anticanres.11812.

Abstract

Background/aim: The present study aimed to compare the utility of various inflammatory marker- and nutritional status-based prognostic factors, including many previous established prognostic factors, for predicting the prognosis of stage IV gastric cancer patients undergoing non-curative surgery.

Patients and methods: A total of 33 patients with stage IV gastric cancer who had undergone palliative gastrectomy and gastrojejunostomy were included in the study. Univariate and multivariate analyses were performed to evaluate the relationships between the mGPS, PNI, NLR, PLR, the CONUT, various clinicopathological factors and cancer-specific survival (CS).

Results: Among patients who received non-curative surgery, univariate analysis of CS identified the following significant risk factors: chemotherapy, mGPS and NLR, and multivariate analysis revealed that the mGPS was independently associated with CS.

Conclusion: The mGPS was a more useful prognostic factor than the PNI, NLR, PLR and CONUT in patients undergoing non-curative surgery for stage IV gastric cancer.

Keywords: Glasgow prognostic score; Stage IV gastric cancer; neutrophil to lymphocyte ratio; non-curative surgery.

MeSH terms

  • Aged
  • Biomarkers, Tumor / blood*
  • Female
  • Gastrectomy
  • Humans
  • Inflammation / blood*
  • Inflammation / pathology
  • Inflammation / surgery
  • Kaplan-Meier Estimate
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Neutrophils / pathology
  • Nutritional Status
  • Palliative Care
  • Platelet Count
  • Prognosis*
  • Serum Albumin / isolation & purification
  • Stomach Neoplasms / blood*
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery

Substances

  • Biomarkers, Tumor
  • Serum Albumin